LNCaP95 cells are a model of castration-resistant prostate cancer that demonstrate sustained AR expression, cellular plasticity (Hu et al., 2012) and acquire enzalutamide resistance through activation of the transcription factor Snail (Ware et al., 2016). This evidence concerns the gene SNAI1 and Familial prostate cancer.